Ng. Coldham et al., THE EFFECT OF TREATMENT WITH 4-HYDROXYANDROSTENEDIONE OR MEDROXYPROGESTERONE ACETATE ON HUMAN BREAST-TUMOR REGRESSION, Anticancer research, 13(3), 1993, pp. 753-758
We have assessed cell deletion in breast tumours removed surgically fr
om postmenopausal women by measuring the distribution ratio of acid ph
osphatase activity between the bound (in the lysosome) and free (in th
e phagosome) states. In benign breast tumours the acid phosphatase dis
tribution ratio was much higher than that found in untreated malignant
breast tumours. The acid phosphatase distribution ratio was also meas
ured before and after treatment in malignant breast tumours removed fr
om eight patients treated with 4-hydroxyandrostenedione (4-OH A) and i
n six patients treated with medroxyprogesterone acetate (MPA). Elevate
d acid phosphatase distribution ratios in benign compared with maligna
nt tumours, and in malignant tumours after treatment from four of eigh
t patients treated with 4-OH A and from three of six patients treated
with MPA, may suggest higher cell deletion in these patients.